4//SEC Filing
PROVECTUS BIOPHARMACEUTICALS, INC. 4
Accession 0001140361-14-037562
$PVCTCIK 0000315545operating
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 9:39 PM ET
Size
8.0 KB
Accession
0001140361-14-037562
Insider Transaction Report
Form 4
CULPEPPER PETER R
Chief Financial Officer
Transactions
- Other
Stock Option (right to buy)
2014-10-03−450,000→ 450,000 totalExercise: $0.93From: 2011-09-06Exp: 2021-09-06→ Common Stock (450,000 underlying) - Other
Stock Option (right to buy)
2014-10-03−450,000→ 450,000 totalExercise: $1.00From: 2010-07-22Exp: 2020-07-22→ Common Stock (450,000 underlying)
Footnotes (1)
- [F1]On October 3, 2014, the Reporting Person entered into a rescission agreement with the Issuer for the cancellation of 50% of (i) options to purchase 900,000 shares of the Issuer's common stock granted to the Reporting Person on September 6, 2011 and (ii) options to purchase 900,000 shares of the Issuer's common stock granted to the Reporting Person on July 22, 2010.
Documents
Issuer
PROVECTUS BIOPHARMACEUTICALS, INC.
CIK 0000315545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000315545
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 9:39 PM ET
- Size
- 8.0 KB